Join our upcoming webinar to learn about the MSDA Test in a clinical setting on Dec. 13, 12:00 PM EST Register Today

News & Blog

Catch the latest

Recent Announcements & Press

May 22, 2024

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis- Nature Communications

March 28, 2024

Octave Bioscience Accelerates Leadership in Precision Care for Neurodegenerative Diseases with Addition of World-Class Commercial Executives – Businesswire

January 26, 2024

Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis – Annals of Clinical and Translational Neurology

Octave Note

December 12, 2022

Leveraging Biology for Better Informed Treatment Decisions

November 29, 2022

Precision Medicine: Biomarkers as an Objective Measure

November 8, 2022

Octave at ECTRIMS: An Overview of Scientific Research Presented on Our MS Precision Care Solution

Media Library

Being Diagnosed with Multiple Sclerosis

Series sponsored by Octave. Trying to confirm if you have multiple sclerosis can be a frustrating process. Dealing with a new diagnosis of MS can be overwhelming. On the latest MS Living Well podcast, Dr. Barry Singer & special guests Gamboa and Dr. Jakai Nolan shed light on a positive path forward in living with multiple sclerosis.

Earliest Stages of Multiple Sclerosis

Series sponsored by Octave. Years before the first typical neurological symptoms of MS, such as numbness or visual loss, individuals can have other symptoms that are often overlooked. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Dr. Helen Tremlett and Dr. Erin Longbrake discuss awareness of this stage, known as prodrome, which may lead to earlier detection of MS.

Is My MS Controlled?

Series sponsored by Octave. Knowing which MS changes are significant enough to warrant speaking up about can be hard for patients to determine. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Dr. Jacqueline Nicholas and Dr. James Bowen discuss tools to improve monitoring such as biomarker blood testing.